RGNEF Inhibitors

RGNEF Inhibitors, as listed here, include chemicals that indirectly target RGNEF by affecting the Rho GTPase signaling pathway or related cellular mechanisms. These inhibitors work by modulating the activity of Rho GTPases or influencing the cytoskeletal dynamics and other cellular processes where RGNEF plays a role. Y-27632 and Fasudil are ROCK inhibitors that potentially affect downstream processes of Rho GTPases, which could be influenced by RGNEF's regulatory functions. CCG-1423 and Rhosin specifically target aspects of RhoA signaling, which might be indirectly linked to RGNEF's activity.

NSC23766, a Rac1 inhibitor, and ML141, a Cdc42 inhibitor, target other members of the Rho GTPase family, potentially influencing pathways and processes connected to RGNEF. SMIFH2, an inhibitor of formin-mediated actin assembly, and actin polymerization disruptors like Latrunculin B and Cytochalasin D, can affect cytoskeletal dynamics and cellular functions where RGNEF is likely to be involved. Toxin B from Clostridium difficile broadly inhibits various Rho GTPases, potentially impacting multiple pathways and processes associated with RGNEF. Blebbistatin, an inhibitor of myosin II, and CK-666, targeting the Arp2/3 complex, influence actin and myosin dynamics, which are key components of the cellular processes regulated by RGNEF.